Fadnavis bats for RT-PCR tests over antigen tests for Covid-19 detection

He said the state's Covid-19 prevention strategy must be scientific and not be based on "mere data management or data suppression"

Devendra Fadnavis
"Due to 65 percent failure rate of Antigen testing, RT-PCR is only considered as golden method for testing," he said further in the tweet.
Press Trust of India Mumbai
1 min read Last Updated : Aug 09 2020 | 7:55 PM IST
Maharashtra BJP leader Devendra Fadnavis on Sunday said the state should use its full capacity for RT-PCR testing to detect coronavirus positive cases, and opposed the dominance of antigen tests in the total number of tests conducted.

He said the state's Covid-19 prevention strategy must be scientific and not be based on "mere data management or data suppression".

The former chief minister tweeted, "Out of total 78,711 Covid-19 tests done on August six, 50,421 were antigen tests (64%) & only 27,440 were RT-PCR (34%) 850 tests using other methods. This ratio has to be 1:1 & not 1:2."


"Due to 65 percent failure rate of Antigen testing, RT-PCR is only considered as golden method for testing," he said further in the tweet.

"Maharashtra has 54,000-plus RT-PCR (Real Time- Polymerase Chain Reaction) testing capacity and we must utilise it to the full extent. Our Covid-19 prevention strategy needs a more scientific approach rather than mere data management or data suppression," the leader of opposition in the Assembly said.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusDevendra FadnavisCoronavirus Tests

Next Story